We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Patient Safety Goals for U.S. Labs Detailed for 2009

By Labmedica staff writers
Posted on 24 Jun 2008
A 2009 update of a U.S. More...
national patient safety goals report and related requirements for accredited laboratories, promote specific improvements in patient safety by providing healthcare organizations with proven solutions to persistent patient safety problems.

The Joint Commission (Oakbrook Terrace, IL, USA) announced the modification of The National Patient Safety Goals, which is overseen by the Sentinel Event Advisory Group, a panel that includes patient safety experts, nurses, physicians, pharmacists, and risk managers, who have hands-on experience in addressing patient safety issues in hospitals and other healthcare settings. The goals apply to the more than 15,000 Joint Commission-accredited and -certified health care organizations and programs in the United States.

The Joint Commission also accredits health plans, integrated delivery networks, and other managed care entities. In addition, it provides certification of disease-specific care programs, primary stroke centers, and health care staffing services. An independent, not-for-profit organization, The Joint Commission is the nation's oldest and largest standards setting and accrediting body in health care.

The guidelines include emphasis on correct identification of the patient, especially before invasive procedures; verification that the patient correctly receives all test results; communication between caregivers is improved; hand hygiene guidelines are monitored; and that the patient takes an active interest in his/her own care.

"The 2009 National Patient Safety Goals represent ongoing opportunities for improvement that can immediately benefit patients,” said Mark R. Chassin, M.D., M.P.P., M.P.H., president, The Joint Commission. "By taking action to consistently meet the Goals, health care organizations can substantially improve patient safety in America.”

The Joint Commission seeks to continuously improve the safety and quality of care provided to the public through the provision of healthcare accreditation and related services that support performance improvement in healthcare organizations. The Joint Commission evaluates and accredits more than 15,000 healthcare organizations and programs in the United States, including more than 8,000 hospitals and home care organizations, and more than 6,300 other healthcare organizations that provide long-term care, assisted living, behavioral healthcare, laboratory, and ambulatory care services


Related Links:
The Joint Commission

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
DNA Extraction Kit
MagMAX DNA Multi-Sample Ultra 2.0 Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.